These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 2137545)
1. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Sarfati M; Fournier S; Christoffersen M; Biron G Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545 [TBL] [Abstract][Full Text] [Related]
2. The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts. Fournier S; Tran ID; Suter U; Biron G; Delespesse G; Sarfati M Leuk Res; 1991; 15(7):609-18. PubMed ID: 1830631 [TBL] [Abstract][Full Text] [Related]
3. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590 [TBL] [Abstract][Full Text] [Related]
4. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23). Delespesse G; Sarfati M; Peleman R J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231 [TBL] [Abstract][Full Text] [Related]
5. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells. Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Ricci M; Bosi A; Romagnani S Ric Clin Lab; 1989; 19(2):129-38. PubMed ID: 2528201 [TBL] [Abstract][Full Text] [Related]
6. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. Luo HY; Hofstetter H; Banchereau J; Delespesse G J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018 [TBL] [Abstract][Full Text] [Related]
7. Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia. Genot E; Sarfati M; Sigaux F; Petit-Koskas E; Billard C; Mathiot C; Falcoff E; Delespesse G; Kolb JP Blood; 1989 Nov; 74(7):2455-63. PubMed ID: 2529929 [TBL] [Abstract][Full Text] [Related]
8. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Fournier S; Yang LP; Delespesse G; Rubio M; Biron G; Sarfati M Br J Haematol; 1995 Feb; 89(2):373-9. PubMed ID: 7873388 [TBL] [Abstract][Full Text] [Related]
9. Regulation of IL-4 responsiveness in lymphoma B cells. Tony HP; Lehrnbecher T; Merz H; Sebald W; Wilhelm M Leuk Res; 1991; 15(10):911-9. PubMed ID: 1833595 [TBL] [Abstract][Full Text] [Related]
10. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692 [TBL] [Abstract][Full Text] [Related]
11. IgE synthesis by chronic lymphocytic leukemia cells. Sarfati M; Luo H; Delespesse G J Exp Med; 1989 Nov; 170(5):1775-80. PubMed ID: 2478656 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/Fc epsilon RII monoclonal antibodies. Bonnefoy JY; Shields J; Mermod JJ Eur J Immunol; 1990 Jan; 20(1):139-44. PubMed ID: 1689660 [TBL] [Abstract][Full Text] [Related]
13. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines. Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064 [TBL] [Abstract][Full Text] [Related]
14. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4. Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738 [TBL] [Abstract][Full Text] [Related]
15. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells. Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690 [TBL] [Abstract][Full Text] [Related]
16. Independent regulation of interleukin 4 (IL-4)-induced expression of human B cell surface CD23 and IgM: functional evidence for two IL-4 receptors. Rigley KP; Thurstan SM; Callard RE Int Immunol; 1991 Feb; 3(2):197-203. PubMed ID: 1709049 [TBL] [Abstract][Full Text] [Related]
17. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells. Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823 [TBL] [Abstract][Full Text] [Related]
18. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII). Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311 [TBL] [Abstract][Full Text] [Related]
19. Thromboxane release by lymphokine-differentiated U937 human monocytic cells: response to platelet-activating factor (PAF) and chemotactic peptide (FMLP) but not to low affinity IGE-receptor (Fc epsilon RII/CD23) occupation. Storch J; Edwards RJ; MacDermot J J Leukoc Biol; 1990 Sep; 48(3):266-73. PubMed ID: 2144015 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of formation of IgE-binding factors (soluble CD23)--I. Fc epsilon R II bearing B cells generate IgE-binding factors of different molecular weights. Letellier M; Sarfati M; Delespesse G Mol Immunol; 1989 Dec; 26(12):1105-12. PubMed ID: 2534424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]